HCA Healthcare, Inc. (HCA) To Go Ex-Dividend on September 16th

HCA Healthcare, Inc. (NYSE:HCA) declared a quarterly dividend on Thursday, July 23rd. Shareholders of record on Wednesday, September 16th will be given a dividend of 0.78 per share on Wednesday, September 30th. This represents a c) annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 16th.

HCA Healthcare has raised its dividend by an average of 0.3%per year over the last three years and has increased its dividend annually for the last 6 consecutive years. HCA Healthcare has a payout ratio of 11.1% indicating that its dividend is sufficiently covered by earnings. Analysts expect HCA Healthcare to earn $32.05 per share next year, which means the company should continue to be able to cover its $3.12 annual dividend with an expected future payout ratio of 9.7%.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $427.51 on Monday. The stock has a market capitalization of $92.56 billion, a price-to-earnings ratio of 14.31, a price-to-earnings-growth ratio of 1.40 and a beta of 1.10. The company has a fifty day moving average of $404.99 and a 200-day moving average of $432.69. HCA Healthcare has a 52-week low of $353.99 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. During the same period in the prior year, the business posted $6.84 earnings per share. The company’s revenue was up 8.7% on a year-over-year basis. On average, equities research analysts forecast that HCA Healthcare will post 29.42 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently weighed in on HCA shares. KeyCorp dropped their price objective on HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating for the company in a research note on Monday, July 27th. Morgan Stanley cut their price objective on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a research report on Monday, July 27th. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Weiss Ratings restated a “hold (c+)” rating on shares of HCA Healthcare in a report on Friday, September 4th. Finally, Royal Bank Of Canada restated an “outperform” rating and issued a $435.00 target price on shares of HCA Healthcare in a research note on Tuesday, September 8th. Fourteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $462.64.

About HCA Healthcare

HCA Healthcare, Inc (NYSE:HCA) is a healthcare services company that operates hospitals and other healthcare facilities. Its network provides a broad range of medical services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic services, and maternity care.

The company also operates ambulatory surgery centers, urgent care facilities, physician practices, and other outpatient locations. HCA Healthcare serves patients through facilities located across the United States, as well as through HCA Healthcare UK, its healthcare operations in the United Kingdom.

HCA Healthcare was founded in 1968 by Dr.